Latest news
Top scientists warn of dementia threat to NHS
In an open letter to the Health Secretary Alan Johnson, a coalition of leading scientists slammed the government’s underinvestment in dementia research amid warnings of “catastrophic” economic consequences.
This follows a series of parliamentary questions whereby the government admitted that less than 3% of the Department of Health’s R&D budget is spent on dementia research.
Dementia care currently costs the
In the letter, published in the Times, Prof Simon Lovestone of the
“As the NHS turns 60, the question isn’t whether it will last a further 60 years, but if it can survive the next 20. Funding for dementia research is pitifully low, while care costs are at an all-time high. With the prevalence of dementia expected to double within a generation, the health service as we know it may well be unsustainable. A quarter of the Department of Health’s research budget is spent on cancer research, compared with just 3% invested in finding new ways of preventing or treating dementia. We urgently need to encourage national dementia research strategies to resolve this. The government must greatly increase dementia research funding now, or the NHS won’t survive the next 20 years.”
The UK’s leading dementia research charity, the Alzheimer’s Research Trust, warned of an impending “dementia crisis”.
The charity’s Chief Executive Rebecca Wood said:
“Care costs for dementia are much higher than those for cancer. Yet a quarter of the Department of Health’s R&D budget is spent on cancer research, compared with just 3% on dementia. If underinvestment persists, the economic consequences arising from dementia care costs will be catastrophic. The government must reassert its commitment to social justice and financial prudence by proportionately funding dementia research.”
The government is currently working on a National Dementia Strategy, which addresses three themes: raising awareness, early diagnosis and intervention and improving the quality of care. There is not yet a government-backed dementia research strategy.
The letter was signed by: Prof Simon Lovestone, Chair, Scientific Advisory Board, Alzheimer’s Research Trust, and King’s College,
Rebecca Wood, Chief Executive, Alzheimer’s Research Trust
Prof Nick Fox,
Prof Seth Love,
Prof Gordon Wilcock,
Prof Roy Weller,
Prof Julie Williams,
Prof Richard Morris,
Prof John Mayer,
Prof Lawrence Whalley,
Dr Frank Gunn-Moore,
Dr Calum Sutherland,



